Search
Romifidine
go.drugbank.com/drugs/DB11543ExperimentalVet approvedIt is also used less commonly in a wide variety of other animal species. This drug's chemical structure closely resembles that of clonidine, however, romifidine is not approved for use in humans.
Devafidugene civaparvovec
go.drugbank.com/drugs/DB16790InvestigationalIt uses proprietary zinc finger nucleases (ZFN) that insert a functional copy of the alpha-L-iduronidase (IDUA) enzyme. … Developed by Sangamo Therapeutics, Inc., devafidugene civaparvovec is being investigated for the treatment of mucopolysaccharidosis Type I (MPS I).[L46716]
CY-1503
go.drugbank.com/drugs/DB17605InvestigationalIt was investigated in cardiopulmonary bypass during surgical repair of congenital heart lesions. … CY-1503 is a pentasaccharide ethyl glycoside consisting of one alpha-D-sialylosyl residue as a sodium salt, two beta-D-galactopyranosyl residues, one 2-acetamido-beta-Dglucopyranosyl unit, and one alpha-L-fucopyranosyl
SCIB1
go.drugbank.com/drugs/DB18439InvestigationalIt is being investigated for the treatment of melanoma. … It consists of plasmid DNA molecules that express a modified antibody in human cells, working to stimulate the patient's T cells to have a stronger reaction against melanoma cells.
Mitometh
go.drugbank.com/drugs/DB12117InvestigationalMitometh has been investigated for the treatment of Lung Neoplasms, Untreated Childhood Medulloblastoma, and Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor. … Mitometh is under investigation for the treatment of Adenocarcinoma, Oropharyngeal Neoplasms, Nasopharyngeal Carcinoma, Non-small Cell Lung Cancer, and Stage IV Non-small Cell Lung Cancer, among others
Tasurgratinib
go.drugbank.com/drugs/DB21222InvestigationalTasurgratinib has a monoisotopic molecular weight of 587.27 Da. … The usage of the INN stem '-gratinib' in the name indicates that Tasurgratinib is a fibroblast growth factor receptor (FGFR) inhibitor.
EP-1043
go.drugbank.com/drugs/DB06118ExperimentalThe vaccine consists of a string of 18 HIV-derived major histocompatibility complex (MHC) Class II restricted epitopes, each separated by a spacer designed to optimize potency. … The epitopes included in the vaccine were selected using Epitope Identification System (EIS) and each of them is predicted to be recognized in the majority of the prospective patient population.
Diazepinomicin
go.drugbank.com/drugs/DB12420InvestigationalDiazepinomicin has been used in trials studying the treatment of Glioblastoma Multiforme.
Florfenicol
go.drugbank.com/drugs/DB11413ExperimentalVet approvedFlorfenicol is a fluorinated synthetic analog of thiamphenicol.
IDM-1
go.drugbank.com/drugs/DB05292ExperimentalIDM-1 is IDM’s most advanced antibody-based Cell drug for the treatment of cancer. … It is comprised of MAK(Monocytes-derived Activated Killer) cells associated with MDX-210, a bispecific anti-HER-2/neu antibody developed by Medarex Inc.